Risk factors for severe neonatal hyperbilirubinemia in low and middle-income countries: A systematic review and meta-analysis

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Olusanya, Bolajoko O ^a   Osibanjo, Folasade B ^a   Slusher, Tina M ^b,c  

^a Healthy Start Initiative   (Nigeria)

^b UNIVERSITY OF MINNESOTA   (United States)

^c HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUCURONOSYLTRANSFERASE 1A1;

ARTICLE; BILIRUBIN BLOOD LEVEL; BILIRUBIN INDUCED NEUROLOGIC DYSFUNCTION; BLOOD GROUP ABO INCOMPATIBILITY; DELIVERY; DISEASE ASSOCIATION; DRUG USE; EGYPT; GENETIC POLYMORPHISM; GESTATIONAL AGE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HERBAL MEDICINE; HUMAN; INDIA; JAUNDICE; LOW BIRTH WEIGHT; LOW INCOME COUNTRY; MATERNAL AGE; MIDDLE INCOME COUNTRY; NEONATAL HYPERBILIRUBINEMIA; NEONATAL WEIGHT LOSS; NEPAL; NEUROLOGIC DISEASE; NEWBORN; NEWBORN HEMOLYTIC DISEASE; NEWBORN SEPSIS; NIGERIA; OCCUPATION; PAKISTAN; PRIMIPARA; RACE DIFFERENCE; RELIGION; RISK FACTOR; SEX DIFFERENCE; SOCIAL ASPECTS AND RELATED PHENOMENA; SOCIAL CLASS; SYSTEMATIC REVIEW; UGT1A1 GENE; DEVELOPING COUNTRY; HYPERBILIRUBINEMIA, NEONATAL; INFANT; META ANALYSIS; ODDS RATIO; PUBLISHING; SEVERITY OF ILLNESS INDEX; SOCIOECONOMICS;

SCOPUS;

DEVELOPING COUNTRIES; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT; INFANT, NEWBORN; ODDS RATIO; PUBLICATION BIAS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS;

EID: 84923002957     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117229     Document Type: Article

References (48)

1. The Young Infants Clinical Signs Study Group. (2008) Clinical signs that predict severe illness in children under age 2 months: a multicentre study. Lancet 371:135-142. doi: 10.1016/S0140-6736(08)60106-3 PMID: 18191685
2. Burke BL, Robbins JM, Bird TM, Hobbs CA, Nesmith C, et al. (2009) Trends in hospitalizations for neonatal jaundice and kernicterus in the United States, 1988-2005. Pediatrics 123:524-532. doi: 10.1542/peds.2007-2915 PMID: 19171618
3. Hameed NN, Na' Ma AM, Vilms R, Bhutani VK. (2011) Severe neonatal hyperbilirubinemia and adverse short-term consequences in Baghdad, Iraq. Neonatology 100:57-63. doi: 10.1159/000321990 PMID: 21212697
4. English M, Ngama M, Musumba C, Wamola B, Bwika J, et al. (2003) Causes and outcome of young infant admissions to a Kenyan district hospital. Arch Dis Child 88:438-443. PMID: 12716721
5. Mwaniki MK, Atieno M, Lawn JE, Newton CR. (2012) Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review. Lancet 379:445-452. doi: 10.1016/S0140-6736(11)61577-8 PMID: 22244654
6. Maulik PK, Darmstadt GL. (2007) Childhood disability in low- and middle-income countries: overview of screening, prevention, services, legislation, and epidemiology. Pediatrics 120 Suppl 1:S1-55.
7. American Academy of Pediatrics (AAP). (2004) Management of hyperbilirubinaemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114:297-316. PMID: 15231951
8. National Institute for Health and Clinical Excellence. (2010) Neonatal jaundice. (Clinical guideline 98.) Available: www.nice.org.uk/CG98.
9. Bhutani VK, Zipursky A, Blencowe H, Khanna R, Sgro M, et al. (2013) Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels. Pediatr Res 74 Suppl 1:86-100. doi: 10.1038/pr.2013.208 PMID: 24366465
10. Slusher TM, Zamora TG, Appiah D, Stanke JU, Strand M, et al. (2014) Global burden of severe neonatal hyperbilirubinemia: a systematic review and meta-analysis. JAMA Pediatrics (under review). doi:10.1001/jamapediatrics.2014.2898 PMID: 25546699
11. Kaplan M, Bromiker R, Hammerman C. (2011) Severe neonatal hyperbilirubinemia and kernicterus: are these still problems in the third millennium? Neonatology 100:354-362. doi: 10.1159/000330055 PMID: 21968213
12. Maisels MJ. (2009) Neonatal hyperbilirubinemia and kernicterus-not gone but sometimes forgotten. Early Hum Dev. 85:727-732. doi: 10.1016/j.earlhumdev.2009.09.003 PMID: 19833460
13. Shapiro SM. (2010) Chronic bilirubin encephalopathy: diagnosis and outcome. Semin Fetal Neonatal Med 15:157-163. doi: 10.1016/j.siny.2009.12.004 PMID: 20116355
14. Hansen TW. (2011) Prevention of neurodevelopmental sequelae of jaundice in the newborn. Dev Med Child Neurol 53 Suppl 4:24-28. doi: 10.1111/j.1469-8749.2011.04059.x PMID: 21950390
15. Olusanya BO, Ogunlesi TA, Slusher TM. (2014) Why is kernicterus still a major cause of death and disability in low and middle-income countries? Arch Dis Child 99:1117-1121. doi: 10.1136/archdischild-2013-305506 PMID: 25123403
16. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(6): e1000097. doi: 10.1371/journal.pmed.1000097 PMID: 19621072
17. The World Bank. New country classifications. Washington DC. Available: http://data.worldbank.org/news/new-country-classifications. Accessed: 2014 August 3
18. Wong WC, Cheung CS, Hart GJ. (2008) Development of a quality assessment tool for systematic reviews of observational studies (QATSO) of HIV prevalence in men having sex with men and associated risk behaviours. Emerg Themes Epidemiol 5:23. doi: 10.1186/1742-7622-5-23 PMID: 19014686
19. Borenstein M, Hedges L, Higgins J, Rothstein H. (2007) Comprehensive Meta-analysis version 2. Biostat, Inc. Englewood, NJ.
20. Higgins JP, Thompson SG, Deeks JJ, Altman DG. (2003) Measuring inconsistency in meta-analyses. BMJ 327:557-560. PMID: 12958120
21. Sodeinde O, Chan MC, Maxwell SM, Familusi JB, Hendrickse RG. (1995) Neonatal jaundice, aflatoxins and naphthols: report of a study in Ibadan, Nigeria. Ann Trop Paediatr 15:107-113. PMID: 7677410
22. Arif K, Bhutta ZA. (1999) Risk factors and spectrum of neonatal jaundice in a birth cohort in Karachi. Indian Pediatr 36:487-493. PMID: 10728039
23. Murki S, Kumar P, Majumdar S, Marwaha N, Narang A. (2001) Risk factors for kernicterus in term babies with non-hemolytic jaundice. Indian Pediatr 38:757-762. PMID: 11463962
24. Agrawal SK, Kumar P, Rathi R, Sharma N, Das R, et al. (2009) UGT1A1 gene polymorphisms in North Indian neonates presenting with unconjugated hyperbilirubinemia. Pediatr Res 65:675-680. doi: 10.1203/PDR.0b013e31819ed5de PMID: 19430380
25. Kalakheti BK, Singh R, Bhatta NK, Karki A, Baral N. (2009) Risk of neonatal hyperbilirubinemia in babies born to 'O' positive mothers: A prospective cohort study. Kathmandu Univ Med J 7:11-15. PMID: 19483446
26. Olusanya BO, Akande AA, Emokpae A, Olowe SA. (2009) Infants with severe neonatal jaundice in Lagos, Nigeria: incidence, correlates and hearing screening outcomes. Trop Med Int Health 14:301-310. doi: 10.1111/j.1365-3156.2009.02223.x PMID: 19187520
27. Adebami O. (2011) Factors associated with the incidence of acute bilirubin encephalopathy in Nigerian population. J Pediatric Neurology 9:347-353.
28. Gamaledin R, Iskander I, Seoud I, Aboraya H, Aleksandr A, et al. (2011) Risk factors for neurotoxicity in newborns with severe neonatal hyperbilirubinemia. Pediatrics 28:e925-e931.
29. Ogunlesi TA, Ogunfowora OB. (2011) Predictors of Acute Bilirubin Encephalopathy Among Nigerian Term Babies with Moderate-to-severe Hyperbilirubinaemia. J Trop Pediatr 57:80-86. doi: 10.1093/tropej/fmq045 PMID: 20554515
30. Chawla D, Jain S, Dhir S, Rani S. (2012) Risk assessment strategy for prediction of pathological hyperbilirubinemia in neonates. Indian J Pediatr 79:198-201. doi: 10.1007/s12098-011-0409-x PMID: 21541649
31. Kaur S, Chawla D, Pathak U, Jain S. (2012) Predischarge non-invasive risk assessment for prediciton of significant hyperbilirubinemia in term and late preterm neonates. J Perinatol 32:716-721. doi: 10.1038/jp.2011.170 PMID: 22094493
32. Scrafford CG, Mullany LC, Katz J, Khatry SK, Leclerq SC, et al. (2013) Incidence of and risk factors for neonatal jaundice among newborns in southern Nepal. Trop Med Int Health 18:1317-1328. doi: 10.1111/tmi.12189 PMID: 24112359
33. Tiwari PK, Bhutada A, Agarwal R, Basu S, Raman R, et al. (2014) UGT1A1 gene variants and clinical risk factors modulate hyperbilirubinemia risk in newborns. J Perinatol 34:120-124. doi: 10.1038/jp.2013.140 PMID: 24232666
34. Song JW, Chung KC. (2010) Observational studies: cohort and case-control studies. Plast Reconstr Surg 126:2234-2242. doi: 10.1097/PRS.0b013e3181f44abc PMID: 20697313
35. Lawn JE, Blencowe H, Oza S, You D, Lee AC, et al. (2014) Lancet Every Newborn Study Group. Every Newborn: progress, priorities, and potential beyond survival. Lancet 384:189-205. doi: 10.1016/S0140-6736(14)60496-7 PMID: 24853593
36. GBD Mortality and Causes of Death Collaborators. (2014) Global, regional, and national levels of age-sex specific all-cause and cause-specificmortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, published online Dec 18. Available: http://dx.doi.org/10.1016/S0140-6736(14)61682-2. doi: 10.1016/S0140-6736(14)62428-4 PMID: 25625402
37. Moise KJ Jr. (2002) Management of rhesus alloimmunization in pregnancy. Obstet Gynecol 100:600-611. PMID: 12220785
38. Kaplan M, Hammerman C. (2009) The need for neonatal glucose-6-phosphate dehydrogenase screening: a global perspective. J Perinatol 29 Suppl 1:S46-52.
39. Pao M, Kulkarni A, Gupta V, Kaul S, Balan S. (2005) Neonatal screening for glucose-6-phosphate dehydrogenase deficiency. Indian J Pediatr 72:835-837. PMID: 16272653
40. WHO Working Group. (1981) WHO, glucose-6-phosphate dehydrogenase deficiency. Bull World Health Organ 67:61-67.
41. Olusanya BO, Emokpae AA, Zamora TG, Slusher TM. (2014) Addressing the burden of severe neonatal hyperbilirubinaemia in low and middle-income countries with significant G6PD-deficiency. Acta Paediatr 103:1102-1109.
42. Nair H. (2009) Neonatal screening program for G6PD deficiency in India: need and feasibility. Indian Pediatr 46:1045-1049. PMID: 20061582
43. Hsu J, Fink D, Langer E, Carter ML, Bengo D, et al. (2014) PCR-Based Allelic Discrimination for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in Ugandan Umbilical Cord Blood. Pediatr Hematol Oncol 31:68-75. doi: 10.3109/08880018.2013.860649 PMID: 24308819
44. De Niz M, Eziefula AC, Othieno L, Mbabazi E, Nabukeera D, et al. (2013) Tools for mass screening of G6PD deficiency: validation of the WST8/1-methoxy-PMS enzymatic assay in Uganda. Malar J 12:210. doi: 10.1186/1475-2875-12-210 PMID: 23782846
45. Kaplan M, Slusher T, Renbaum P, Essiet DF, Pam S, et al. (2008) (TA)n UDP-glucuronosyltransferase 1A1 promoter polymorphism in Nigerian neonates. Pediatr Res 63:109-111. PMID: 18043502
46. Berman NG, Parker RA. (2002) Meta-analysis: neither quick nor easy. BMC Med Res Methodol 2:10. PMID: 12171604
47. Biggerstaff BJ, Tweedie RL. (1997) Incorporating variability in estimates of heterogeneity in the random effects model in meta-analysis. Stat Med 16: 753-768. PMID: 9131763
48. Altman DG, Bland JM. (1995) Absence of evidence is not evidence of absence. BMJ 311(7003):485. PMID: 7647644